Lantern Pharma, a pharma company which uses artificial intelligence to develop shelved oncology drugs has joined Genomics England’s groundbreaking industry partnership.
The UK pharma and biotech industries have warned that clarity on Brexit arrangements for medicines is needed urgently - but no deal is in sight just 13 months ahead of its official departur
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.